E Lontchi-Yimagou1, J L Nguewa2, F Assah3, J J Noubiap4, P Boudou5, E Djahmeni3, E V Balti6, B Atogho-Tiedeu1, J F Gautier2,5, J C Mbanya1,3,7, E Sobngwi1,3,7. 1. Laboratory for Molecular Medicine and Metabolism, Biotechnology Center, University of Yaoundé I, Yaoundé, Cameroon. 2. INSERM, UMRS 1138, Centre de Recherche des Cordeliers, Paris, France. 3. National Obesity Centre, Yaoundé Central Hospital, Yaoundé, Cameroon. 4. Department of Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa. 5. Saint-Louis University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France. 6. Diabetes Research Center, Brussels Free University-VUB, Brussels, Belgium. 7. Department of Internal Medicine, University of Yaoundé I, Yaoundé, Cameroon.
Abstract
AIM: It is unclear whether ketosis-prone diabetes is a specific type or a subtype of Type 2 diabetes. We aimed to describe the clinical and metabolic features of ketosis-prone diabetes in a sub-Saharan population. METHODS: We consecutively enrolled and characterized 173 people with non-autoimmune diabetes admitted for hyperglycaemic crisis at the Yaoundé Central Hospital, Cameroon. Blood samples were collected for fasting glucose, HbA1c , lipid profile and C-peptide assays with insulin resistance and secretion estimation by homeostasis model assessment. People were classified as having Type 2 diabetes (n = 124) or ketosis-prone diabetes (n = 49). Ketosis-prone diabetes was sub-classified as new-onset ketotic phase (n = 34) or non-ketotic phase (n = 15). RESULTS: Ketosis-prone diabetes was found in 28.3% of the hyperglycaemic crises. Age at diabetes diagnosis was comparable in Type 2 and ketosis-prone diabetes [48 ± 14 vs 47 ± 11 years; P = 0.13] with a similar sex distribution. Overall BMI was 27.7 ± 13.4 kg/m2 and was ≥ 25 kg/m2 in 55.8% of those taking part, however, 73.5% of those with ketosis-prone diabetes reported weight loss of > 5% at diagnosis. Blood pressure and lipid profile were comparable in both types. Ketosis-prone diabetes in the ketotic phase was characterized by lower insulin secretion and higher serum triglycerides compared with non-ketotic ketosis prone and Type 2 diabetes. Type 2 and ketosis prone diabetes in the non-ketotic phase were comparable in terms of lipid profile, blood pressure, waist-to-hip ratio, BMI and fat mass, insulin secretion and insulin resistance indices. CONCLUSIONS: Ketosis-prone diabetes is likely to be a subtype of Type 2 diabetes with the potential to develop acute insulinopenic episodes.
AIM: It is unclear whether ketosis-prone diabetes is a specific type or a subtype of Type 2 diabetes. We aimed to describe the clinical and metabolic features of ketosis-prone diabetes in a sub-Saharan population. METHODS: We consecutively enrolled and characterized 173 people with non-autoimmune diabetes admitted for hyperglycaemic crisis at the Yaoundé Central Hospital, Cameroon. Blood samples were collected for fasting glucose, HbA1c , lipid profile and C-peptide assays with insulin resistance and secretion estimation by homeostasis model assessment. People were classified as having Type 2 diabetes (n = 124) or ketosis-prone diabetes (n = 49). Ketosis-prone diabetes was sub-classified as new-onset ketotic phase (n = 34) or non-ketotic phase (n = 15). RESULTS:Ketosis-prone diabetes was found in 28.3% of the hyperglycaemic crises. Age at diabetes diagnosis was comparable in Type 2 and ketosis-prone diabetes [48 ± 14 vs 47 ± 11 years; P = 0.13] with a similar sex distribution. Overall BMI was 27.7 ± 13.4 kg/m2 and was ≥ 25 kg/m2 in 55.8% of those taking part, however, 73.5% of those with ketosis-prone diabetes reported weight loss of > 5% at diagnosis. Blood pressure and lipid profile were comparable in both types. Ketosis-prone diabetes in the ketotic phase was characterized by lower insulin secretion and higher serum triglycerides compared with non-ketotic ketosis prone and Type 2 diabetes. Type 2 and ketosis prone diabetes in the non-ketotic phase were comparable in terms of lipid profile, blood pressure, waist-to-hip ratio, BMI and fat mass, insulin secretion and insulin resistance indices. CONCLUSIONS:Ketosis-prone diabetes is likely to be a subtype of Type 2 diabetes with the potential to develop acute insulinopenic episodes.
Authors: Davis Kibirige; William Lumu; Angus G Jones; Liam Smeeth; Andrew T Hattersley; Moffat J Nyirenda Journal: Clin Diabetes Endocrinol Date: 2019-02-14
Authors: Charlotte Bavuma; Diomira Sahabandu; Sanctus Musafiri; Ina Danquah; Ruth McQuillan; Sarah Wild Journal: J Glob Health Date: 2019-12 Impact factor: 4.413
Authors: J Damascene Kabakambira; Rafeal L Baker; Sara M Briker; Amber B Courville; Lilian S Mabundo; Christopher W DuBose; Stephanie T Chung; Robert H Eckel; Anne E Sumner Journal: BMJ Glob Health Date: 2018-10-15
Authors: Eric Lontchi-Yimagou; Philippe Boudou; Jean Louis Nguewa; Jean Jacques Noubiap; Vicky Kamwa; Eric Noel Djahmeni; Babara Atogho-Tiedeu; Marcel Azabji-Kenfack; Martine Etoa; Gaelle Lemdjo; Mesmin Yefou Dehayem; Jean Claude Mbanya; Jean-Francois Gautier; Eugène Sobngwi Journal: J Diabetes Metab Disord Date: 2018-03-29